1. Home
  2. RVPH vs PRPL Comparison

RVPH vs PRPL Comparison

Compare RVPH & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • PRPL
  • Stock Information
  • Founded
  • RVPH 2006
  • PRPL 2010
  • Country
  • RVPH United States
  • PRPL United States
  • Employees
  • RVPH N/A
  • PRPL N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • PRPL Home Furnishings
  • Sector
  • RVPH Health Care
  • PRPL Consumer Discretionary
  • Exchange
  • RVPH Nasdaq
  • PRPL Nasdaq
  • Market Cap
  • RVPH 88.0M
  • PRPL 90.3M
  • IPO Year
  • RVPH N/A
  • PRPL N/A
  • Fundamental
  • Price
  • RVPH $1.90
  • PRPL $1.03
  • Analyst Decision
  • RVPH Strong Buy
  • PRPL Buy
  • Analyst Count
  • RVPH 5
  • PRPL 3
  • Target Price
  • RVPH $11.40
  • PRPL $1.70
  • AVG Volume (30 Days)
  • RVPH 1.7M
  • PRPL 542.2K
  • Earning Date
  • RVPH 11-14-2024
  • PRPL 03-11-2025
  • Dividend Yield
  • RVPH N/A
  • PRPL N/A
  • EPS Growth
  • RVPH N/A
  • PRPL N/A
  • EPS
  • RVPH N/A
  • PRPL N/A
  • Revenue
  • RVPH N/A
  • PRPL $504,838,000.00
  • Revenue This Year
  • RVPH N/A
  • PRPL N/A
  • Revenue Next Year
  • RVPH N/A
  • PRPL $1.83
  • P/E Ratio
  • RVPH N/A
  • PRPL N/A
  • Revenue Growth
  • RVPH N/A
  • PRPL N/A
  • 52 Week Low
  • RVPH $0.60
  • PRPL $0.75
  • 52 Week High
  • RVPH $4.83
  • PRPL $2.33
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 58.09
  • PRPL 53.43
  • Support Level
  • RVPH $1.97
  • PRPL $1.04
  • Resistance Level
  • RVPH $2.15
  • PRPL $1.10
  • Average True Range (ATR)
  • RVPH 0.15
  • PRPL 0.10
  • MACD
  • RVPH 0.02
  • PRPL -0.01
  • Stochastic Oscillator
  • RVPH 78.74
  • PRPL 31.75

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

About PRPL Purple Innovation Inc.

Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms, and other products. It sells its products through online channels, traditional wholesale partners and third-party online retailers.

Share on Social Networks: